insulin-detemir and Candidiasis--Invasive

insulin-detemir has been researched along with Candidiasis--Invasive* in 1 studies

Other Studies

1 other study(ies) available for insulin-detemir and Candidiasis--Invasive

Article	Year
Association of IL-17 Inhibitor and SGLT2 Inhibitor with Candida Pyelonephritis. The American journal of medicine, 2021, Volume: 134, Issue:11 Topics: Antibodies, Monoclonal, Humanized; Benzhydryl Compounds; Candida glabrata; Candidiasis, Invasive; Dermatologic Agents; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypoglycemic Agents; Insulin Detemir; Liraglutide; Middle Aged; Psoriasis; Pyelonephritis; Recurrence; Sepsis; Sodium-Glucose Transporter 2 Inhibitors; Urinary Tract Infections	2021

Article

Year

Association of IL-17 Inhibitor and SGLT2 Inhibitor with Candida Pyelonephritis.

The American journal of medicine, 2021, Volume: 134, Issue:11

Topics: Antibodies, Monoclonal, Humanized; Benzhydryl Compounds; Candida glabrata; Candidiasis, Invasive; Dermatologic Agents; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypoglycemic Agents; Insulin Detemir; Liraglutide; Middle Aged; Psoriasis; Pyelonephritis; Recurrence; Sepsis; Sodium-Glucose Transporter 2 Inhibitors; Urinary Tract Infections

2021